The 12 closest competitors and alternatives to BioMed Partners among venture capital companies — ranked by similarity to what BioMed Partners actually does, not by market-cap band.
Subscribe to see BioMed Partners’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioMed Partners (BiomedVC) is a venture capital firm that invests in early-stage life science startups in continental Europe, with a focus on Switzerland and Germany. The firm provides initial investments at the Seed and Series A stages to help entrepreneurs translate academic scientific innovations into venture-backed biotech companies developing therapeutics for high-unmet medical needs.
BioMed Partners is a venture capital company. Xcout tracks 12 named people at BioMed Partners, including Stefan Fäs (CFO, Partner).
6 more named people on record for BioMed Partners, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to BioMed Partners by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Venture Capital and Private Equity
AdBio Partners is a venture capital firm that invests in and develops early-stage life sciences and biotech startups across Europe. The company partners with academic institutions and scientific founders to fund breakthrough medical discoveries and therapeutic innovations.
Similar venture capital company
VP Venture Partners is a private venture capital firm based in Zurich, Switzerland, that supports early-stage life science companies in Europe.
Similar venture capital company
BioMed Ventures is a life science venture capital firm that operates as an investment arm of BioMed Realty. The firm focuses on investing in early- and growth-stage companies within the biotechnology and medical sectors.
Similar venture capital company
Biovance Capital is a venture capital firm that invests in early-stage, seed, and Series A biopharmaceutical companies across Europe. The firm focuses on supporting the development of transformational medical treatments and building companies across various therapeutic areas and modalities.
Venture Capital & Private Equity
Ventura BioMed Investors is a venture capital firm focusing on early-stage life science and biomedicine investments within Europe.
Similar venture capital company
Biovision Ventures is a venture capital firm that invests in early-stage companies focusing on therapeutics, medtech, and bio-IT within the US and Europe. The firm targets private companies developing novel platform-based therapies and medical software solutions, typically participating from Series Seed to Series B financing rounds.
Venture Capital and Private Equity
Thuja Capital is an early-stage venture capital firm that invests in innovative life science companies located in Europe. The firm partners with visionary CEOs and leverages its sector expertise and industry network to help build healthcare businesses.
Similar venture capital company
TVM Capital Life Science is a venture capital firm that invests in life science innovations, including early-stage therapeutics, commercial-stage medtech, diagnostics, and digital health products. The firm provides capital and expertise to portfolio companies in North America and Europe to help bring new therapies and medical products to market.
Similar venture capital company
Mission Bay Capital is an early-stage life science venture capital firm that invests in and supports startup companies in the life sciences sector. The firm operates venture capital funds to enable early-stage businesses in this industry.
Similar venture capital company
Boutique Venture Partners is a venture capital firm that provides early-stage funding to startups in the healthcare, life sciences, biotech, medtech, healthtech, and frontier technology sectors. Led by a team of scientists and clinicians, the firm invests in science-driven companies developing disruptive technologies aimed at improving human and planetary health.
Venture Capital & Private Equity
Research Bridge Partners makes formative seed investments in biomedical startups founded on scientific breakthroughs from researchers at mid-continent research universities. The company identifies overlooked academic innovations, establishes operational and governance infrastructure, and deploys capital to scale companies for early clinical development.
Similar venture capital company
MintPharma Capital is a venture capital firm that invests in early-stage biotechnology and pharmaceutical companies. The firm targets seed and Series A rounds, typically providing between $2 million and $7 million to support the development of first-in-class therapies and life sciences innovations.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for BioMed Partnersand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →